CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Acquisition or sale completed
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 289,118 shares at $5.00 ($1,445,590)
- 4 Open-market buy Chief Executive Officer bought 97,431 shares at $5.00 ($487,155)
- 4 Open-market buy Director bought 314,066 shares at $5.00 ($1,570,330)
- 4 Open-market buy Director bought 1,455,132 shares at $5.00 ($7,275,660)
- 4 Open-market buy Director bought 1,455,132 shares at $5.00 ($7,275,660)
Page 17 of 19 · 362 filings